ED Provider Notes
NG at 8/21/2023 5:18 PM
Attestation signed by JSF at 8/24/2023 1:25 AM
08/24/23
ATTESTATION:
My date of service is 8/21/2023. I was present for and performed key portions of the examination of the patient. I am personally involved in the management of the patient. I agree with the findings and care plan as documented by the resident.
EMERGENCY DEPARTMENT PHYSICIAN NOTE
ED Attending(s): JSF 8/21/2023 15:37
Chief Complaint
Patient presents with
*Poor balance
Loss of balance since midnight - noticed when walking to bathroom with associated fall injuring R lower ribs (no trouble breathing, no LOC), No pronator drift, no facial asymmetry. Chronic hand tremors noted. Code stroke called 1522.
Allergen | Reactions |
---|---|
*Colesevelam | Pt gets weak |
*Pregabalin | |
*Tamsulosin | Pt may have had a medication interaction. Pt states he became weak when taking Flomax. MD L aware |
Procedure | Laterality | Date |
---|---|---|
ABDOMEN SURGERY | > | |
Cataract Surgery | bilateral | |
ESOPHAGUS SURGERY | esophageal carcinoma | |
HEMICOLECTOMY | Right | 9.29.14 |
lap | ||
HIP SURGERY | M/tr> |
Family History | |||
---|---|---|---|
Problem | Relation | Name | Age of Onset |
Colon cancer | Mother | Helen | 96 |
Bladder cancer | Father | Richard | 73 |
Leukemia | Maternal Grandmother | Blanch | |
Heart disease | Paternal Grandmother | Marie | |
Prostate cancer | Paternal Grandfather | Gabriel | |
Colon cancer | Maternal Aunt | Charlotte | |
Breast cancer | Maternal first cousin | Wendy | 50 |
Malig hyperten Neg Hx | Maternal first cousin | Wendy |
Social History | |
---|---|
Socioeconomic History | |
*Marital status | Single |
Tobacco Use | |
*Smoking status: | Former |
Packs/day: | 1 |
Years: | 10.00 | Pack years: | 10 |
Types: | Cigarettes, Cigar |
*Smokeless tobacco: | Never |
*Tobacco comments: quit 1969 | |
Substance and Sexual Activity | |
*Alcohol useL | No |
Alcohol/week: | 0.8 standard drinks |
Types: | 1 Standard drinks ore equivalent per week |
Comment: Rare ETOH | |
*Drug use: | No |
*Sexual activity: | Yes |
Partners: | Female |
Ddx includes CVA, TIA, intracranial hemorrhage/mass, seizure (although no abnormal movements seen), hypotension (BP normal since arrival), infectious etiology (although no signs or symptoms), electrolyte/metabolic abnormality. Exam only notable for unsteady gait and balance. No other focal neurological deficits found. On labs, lactate elevated to 5.4 with unclear source since low concern for seizure, no recent decreased PO intake/vomiting, no abdominal or chest pain, no substance use. CXR normal without any focal consolidation or edema.
1700 | Neuro: MRI brain focused, CT spine w/o, A1c, b12, spep, PT Eval |
1754 | CT Stroke Protocol |
IMPRESSION: | |
1. No acute intracranial hemorrhage, hydrocephalus, or herniation. | |
2. No large vessel intracranial occlusion or significant arterial narrowing in the head or neck. | |
3. Multilevel cervical spondylosis, as described, with possibly severe narrowing of the bony spinal canal at C7-T1. The degree of bony canal stenosis is likely not significantly changed since 2015. | |
4. Findings possibly suggestive of right vocal cord paralysis; correlate with clinical symptoms. | |
1756 | Orthostatic vitals negative per bedside RN |
2043 | Ordered night time meds |
2259 | 10:59 PM |
RET, MD received sign-out from off going resident: | |
S81M p/w code stroke. Lactate 5.4. Neuro exam nonfocal?Rhomberg | |
-MRI brain c/spine | |
-Neurorecs | |
-Lactate [RT] | |
0023 | Lactate, whole blood: 0.9 [RT] |
0152 | Reached out to neuro for recs[RT] |
0338 | MR Brain without Contrast - Focused Brain |
BRAIN: | |
No acute hemorrhage. No herniation. Periventricular and deep white matter foci of T2/FLAIR signal hyperintensity, nonspecific, likely related to chronic microvascular ischemic change. No convincing evidence of any true reduced diffusion. Focal susceptibility signal in a region of FLAIR hyperintensity in the right centrum semiovale, most likely chronic microhemorrhage. | |
Focal area of smooth dural thickening overlying the right frontal lobe measures up to 10 mm (series 600, image 441), is T1 isointense, mildly FLAIR hyperintense, and without abnormal susceptibility/reduced diffusion. There may be a thin posterior dural tail. Lesion is overall suggestive of a small meningioma without significant local mass effect. In retrospect this is visible on the recent companion CT brain but not on remote CT imaging from 2014. | |
Ventricles within normal limits of size for age. | |
No extra-axial collection. | |
Maintained vascular flow voids. | |
CERVICAL SPINE: | |
Multilevel cervical degenerative changes, including areas of disc osteophyte complex formation, uncovertebral hypertrophy, facet hypertrophy, and ligamentum flavum thickening, as suggested on CT. Ligamentum flavum thickening is more conspicuous on MRI, particularly at C5-C6. Findings are contributing to mild spinal canal narrowing at C3-C4, moderate to severe narrowing at C4-C5,severe narrowing at C5-C6, and moderate to severe narrowing at C7-T1. | |
Mild deformity of the right lateral cord at C5-C6 due to external mass effect. No convincing evidence of any true cord signal abnormality. | |
Degenerative neural foraminal narrowing, multilevel, is moderate to severe on the left at C2-C3, severe on the left at C3-C4 and C4-C5 (and moderate-to-severe on the right at C4-C5), and severe bilaterally at C5-C6. | |
PRELIMINARY REPORT. FULL REPORT AND ADDITIONAL DETAILS TO FOLLOW. | |
[RT] | |
0338 | Reached out to neurology for recs[RT] |
0343 | Will page with NSGY for MRI findings Mild deformity of the right lateral cord at C5-C6 due to external mass effect. If NSGY will not admit, then CDU for PT/OT. If admit, then follow-up Neuro after PT/OT.[RT] |
0432 | Paged NSGY[RT] |
0517 | Paged NSGY[RT] |
0517 | NSGY at bedside[RT] |
0623 | NSGY (Dr. VL) will staff with attending and inform day ED team of plan [RT] |
0702 | S 81 y.o. gait disturbance, Code stroke; cord signal abnormality at c5-6 |
 : | -follow up nsgy [EK] |
0846 | Nsg repaged [EK] |
0851 | Cleared by NSGY for discharge, no acute interventions. [EK] |
ED Course User Index | |
---|---|
[EK] EJK, MD | |
[RT] RET, MD | |
NG, MD | |
Resident | |
08/21/23 1749 | |
JSF, MD | |
08/24/23 0125 |
My date of service is 08/22/23. | |
I was either virtually or physically present for key portions of the encounter and am personally involved in | |
the management of the patient. I reviewed, verified, and revised the note as necessary. | |
Reason for Consultation | |
Falls, weakness, Code Stroke | |
Mr. R is a 81 year old man with fibromyalgia, history of MDD, who presented with acute gait difficulty and was activated as Code Stroke. He noted instability when getting up to urinate at night and fell down without head strike. He went back to bed and slept but yesterday morning continued to feel unstable and so came to ED. He had NIHSS 0 and did not receive IV tPA; CT Angiogram, showed no evidence of LVO. Per chart, his medications include: Amitriptyline, NuVigil, Brexpiprazole, Wellbutrin, Gabapentin, Norco as needed, Methylphenidate, Melatonin, and, Ziprasidone. Of note, he recently started tricyclic and decreased Wellbutrin dosing.
Medication | Instruction |
---|---|
* acetaminophen (TYLENOL) | 1000 mg, Oral, Every 6 Hours PRN |
* acetylcarnitine (ACETYL_L_CARNITINE) 500 mg capsule | 2 tablets, Oral, Daily Schedule |
* ARMODAFINIL ORAL | 250 mg, Oral, Daily With Dinner Scheduled |
* atorvastatin (LIPITOR) | 20 mg, Oral, Daily Scheduled |
* buPROPion (WELLBUTRIN SR) | 200 mg, Twice Daily |
* cholecalciferol (vitamin D3) | 5000 Units, Oral, Daily Scheduled |
* ciclopirox (LOPROX) 0.77% TOPICAL SUSPSENSION | Topical, 2 Times Daily Scheduled, Use as instructed |
* coenzyme Q10 | 800 mg, Oral, Daily with Lunch Scheduled |
* ferrous furnarate-iron polysaccharide complex (TANDEM) 162-115.2 (106) mg capsule | Oral, Every Other Day, 18 mg every other day |
* finasteride (PROSCAR) 5 mg tablet | TAKE 1 TABLET DAILY (MAY TAKE 3 MONTHS FOR FULL EFFECT) |
* GABAPENTiN ORAL | 700 mg, Oral, Twice Daily |
* GLUTATHIONE, BULK, MISC | Misc.(Non-Drug, Combo Route), Glutathione suppository 1 gm each 4 times per week |
* IRON/FA/DHA/EPA/FAD/NADH/MV47 (ENLYTE ORAL) | 1 capsule, Oral, Daily Scheduled |
* LEVOCARNITINE (L-CARNITINE ORAL) | 1 capsule, Oral, Daily Scheduled |
* LEVODCARNITINE HCL (ACETYL-L-CARNITINE MISC) | 500 mg, Daily Scheduled |
* MAGNESIUM GLYCINATE ORAL | 360 mg, Oral, Daily Scheduled |
* melatonin | 6 mg, Oral Daily At Bedtime Scheduled |
* methenamine (MANDELAMINE) 1 GM tablet | TAKE 1 TABLET EVERY MORNING AND AT BEDTIEME STOP TAKING IF YOU GO ON ANTIBIOTICS AND RESUME AFTER ANTIBIOTICS COMPLETE |
* METHYLPHENIDATE ORAL | 65 mg, I take 45 mg breakfast 20 mg Noon |
* naphazoline HXL/pheniramine (VISINE-A OPHTH) | Ophihalmic |
* NONFORMULARY REEQEST | ATP360 4 capsules per day |
* ondansetron (ZOFRAN) | Take 8 mg po every 6-8 hours up to two doses, as needed for nausea related to colonoscopy prep |
* ondansetron (ZOFRAN) | 8 mg, Oral Every 8 Hours PRN, Take one tab every 6-8 hours |
* pantoprazole (PROTONIX) | 40 mg, Oral, Daily Scheduled |
* polyethylene glycol-electrolytes (GOLYTELY) 236-22.74-6.74-5.86 gram solution | 2 day prep - 2 containers |
* REXULTI 2 mg TAB | 1 tablet, Oral; Daily Scheduled |
* simethicone (MYLICON) 125 mg chewable tablet | PLEASE PURCHASE OVER THE CCOUNTER. PLEASE TAKE 3 TABLETS (approx. 400 mg) THE NIGHT BEFORE THE PROCEDURE and 3 TABLETS (approx. 400 mg) THE MORNING OF WHILE DRINKING THE BOWEL PREP |
* simethicone (MYLICON) 125 mg chewable tablet | PLEASE PURCHASE OVER THE COUNTER, PLEASSE TAKE 3 TABLETS (approx. 400 mg) THE MORNING OF WHILE DRINKING THE BOWEL PREP. |
* terazosin (HYTRIN) | 10 mg, Oral, Daily Scheduled |
* UNABLE TO FIND | Med Name: D-Mannose 2000 mg per day |
* UNABLE TO FIND | Med Name: Elura 36 mg per day |
* UNABLE TO FIND | Med NameL Pure Adrenal 400 5 caps/day |
* UNABLE TO FIND | Med Name: SafeCell Glutathione 600 mg/day |
* UNABLE TO FIND | Med Name: SamE 2000 mg/day |
* UNABLE TO FIND | Med Name: Zinc Carnosine 16 mg/day |
* UNABLE TO FIND | Med Name: GI Detox 2 caps/day |
* vortioxetine (TRINTELLIX) | 10 mg, Oral, Daily Scheduled |
* ziprasidone (GEODON) | 120 mg, Oral, Daily with Dinner Scheduled |
MDM Complexity of Problems
Illness/injury posing threat to life or bodily function: Gait Difficulty and falls.
MDM Complexity Risk
No additional complexity risk
Problem List/Plan
81 year old man with MDD, fibromyalgia, polypharmacy on multiple CNS active medications including stimulants, serotoninergic medications, and neuroleptics (no significant recent changes aside from cross-tapering of Wellbutrin with Amitriptyline) who came to ED with fall last night and gait imbalance.
Patient has outpatient neurologist and can f/up with them to address above follow-up issues. He should also f/u with PCP. Discussed with ED Dr. G myself.
TJR is a 81 y.o. man with a history of fibromyalgia presenting with acute gait instability. Neurology was consulted for code stroke.
Patient last seen normal 12AM 8/21. Patient was in usual state of health until he got up at night to urinate and noticed he was very unstable. He fell over, no head strike or LOC, then headed to bed again and went to sleep. He woke up today and noticed he was still feeling unstable having trouble turning while walking, and decided to present to the ED as he was not improving.
Patient denies ever having this type of symptom before, denies headaches, vision troubles, dizziness, chest pain, shortness of breath, abdominal pain, nausea, vomiting, diarrhea.
Patient was followed by neurology in 2022 for post-viral fatigue and myalgias. Patient states he has had bilateral tremors for many years but never saw a doctor for this.
CT stroke protocol showed no evidence of intracranial hemorrhage, large territory ischemic infarct, hydrocephalus, herniation, midline shift, mass effect, or large vessel occlusion.
Patient was not a tPA candidate and did not receive IV therapy due to out of window. Given absence of large vessel occlusion patient was not an endovascular thrombectomy candidate.
Allergen | Reactions |
---|---|
*Colesevelam | Pt gets weak |
*Pregabalin | |
*Tamsulosin | Pt may have had a medication intersction. Pt states he became weak when taking flomax. MD L aware |
*Smoking status: | Former |
Packs/day | 1.00 |
Years: | 10.00 |
Pack Years: | 10.00 |
Types: | cigarettes,Cigars |
*Smokeless tobacco | Never |
*Tobacco comments: | Quit 1969 |
*Alcohol use: | No |
Alcohol/week: | 0.8 standard drinks |
Types:: | 1 Standard drinks or equivalent per week; |
Comment: Rare ETOH | |
*Drug use: | No |
*Sexual activity: | Yes |
Partners: | Female |
Delt | Biceps | Triceps | WE | FE | IO | |
---|---|---|---|---|---|---|
Right | 5 | 5 | 5 | 5 | 5 | 5 |
Left | 5 | 5 | 5 | 5 | 5 | 5 |
IP | Hams | Quads | TA | EHL | |
---|---|---|---|---|---|
Right | 5 | 5 | 5 | 5 | |
Left | 5 | 5 | 5 | 5 | 5 |
Reflexes: R/L: Bi 3/3, Brachiorad 3/3, Patella 3/3, Ankle jerka 2+/2+
Sensory: Intact to LT throughout. UTA Romberg as he is unable to stand steady with eyes open.
Coordination: Intact FNF, HTS
Gait: Difficult to assess given postural instability. ?wide base gait, holding on to walls while walking, 7 step turns.
LABS:
Recent Labs
08/21/23 1537 | |
WBC | 7.1 |
HGB | 12.4* |
HCT | 37.5* |
PLT | 204 |
NA | 138 |
K | 4.7 |
CL | 103 |
CO2 | 21* |
BUN | 25 |
CREAT | 1.17 |
GLU | 111 |
CA | 9.6 |
PT | 13.6 |
INR | 1.1 |
PTT | 20.1* |
09/21/23 1537 | |
CA | 9.6 |
08/21/23 1537 | |
PT | 13.6 |
INR | 1.1 |
PTT | 20.1* |
Component | Value | Date |
TSH | 2.07 | 02/20/2014 |
FT4 | 12 | 05/14.2001 |
CK | 391(H) | 02/19/2014 |
Component | Value | Date |
---|---|---|
Glucose, CSF | 84 (H) | 02/21/2014 |
Protein, Total, CSF | 59 (H) | 02/21/2014 |
WBCs, CSF | 1 | 02/21/2014 |
RBCs, CSF | 7(a) | 02/21/2014 |
%Lymphs, CSF | 42 | 02/21/2014 |
No results found for: COCC, COCF, GMAN, T253, P256N, P284. H1377, H2377. T339, VDRL, VZGC. VZMC, CMVMIS, EBVMIS, TOXO, TOGM, HIVAA1, LYMET, HCV, HBABQ, CORM, HBSAG, HTLV12. TREP, QTFN, LEGAU, VCAM, EBNA, CMVQT, T401, T290
No results found for: RF, AP3A, AMYE, TGAB, ATPO, ANA, DSDNA, C3, C4, GAD, GD1A, GD1AM, GQ1B, SSB, RO52, RO60, TRANSGLU, CYCP, IGM, IGG, ESR, CRP, CRYF, CRYGL, HEXA, ACLM, ACLG, B2GPG. B2GPM, ENCES, ENCEC, NMO
Component | Value | Date |
Ammonia | 24 | 02/19/2014 |
MMA, Serum | 0.18 | 02/23/2014 |
uPEP Interpretation | Negative | 02/19/2014 |
%M-Protein (monoclonal), Urine | Negative | 02/19/2014 |
Creatine kinase, total | 391 (H) | 02/19/2014 |
Component | Value | Date |
---|---|---|
Thyroid Stimulating Hormone | 2.07 | 02/20/2014 |
Free T4 | 12 | 05/14/2001 |
Order | Current Status |
Type and screen | In process |
Date Collected | Specimen | Source | Result |
Exam concerning for rigitity, bradykinesia, tremor, en block turning concerining with parkinsonism as well as wide base gait, holding on to walls of c/f sensory ataxia. Patient also reported lightheadedness when changing positions c/f orthostasis. Overall, presentation multifactorial. Given acuiy of symptom onset per patient, recommend MRI focused brain and C-spine as he also fell and has hyperreflexia. Given signs of sensory ataxia, though no numbness on exams, recommend neuropathy labs (A1c, SPEP. B12). Finally. as a patient is reprting lighthhededness and has an elevated lactate, recommend orthostatic vitals and fluids as needed.
Charting Type: Initial Evaluation
Assessment: Patient is an 81 year old male with hx of fibromyalgia and multiple prior cancers (colon/esophageal/prostate) p/w acutely worsened gait since 8/21 w/ falling to thet L side (no trauna prior to gait difficulties) f/t/h cervicasl degenerative chasnges most severe at C5-C6 with central canal narrowing without cord signal change and R>L neuroforaminal stenosis from C2-C6. MRI Brain revealed an incidental 1.0 cm R frontal dural based mass without local mass effect or sulcal effacement concerning for a meningioma. Prior to admission, patient was independent with mobility without use of AD and able to complete most of his ADLs. Patient states that he relies on grocery deliveries and uses Uber to access the comnmunity. Patient noted to have mild instability on feet with increased retropulsion without use of AD. Patient had significant improvements with overall stability and safety with use of FWW. Patient exhibited shuffling and at times, festinating gait pattern specifically with turns, requiring extra time to complete. Patient exhibited parkinsonism like deficits with activity and will benefit from outpatient follow up. Patient is safe to discharge home with home health PT and FWW provided at bedside.
History of Present Illness
81M hx of fibromyalgia and multiple prior cancers (colon/esophageal/prostate) p/w acutely worsened gait since 8/21 w/falling to the L side (no trauma prior to gait difficulties) f/t/h cervical degenerative changes most severe at C5-C6 with central canal narrowing without cord signal change and R>L neuroforaminal stenosis from C2-C6. MRI Brain revealed an incidental 1.0 cm R frontal dural based mass without local mass effect or sulcal effacement concerning for a meniongioma.
Per the patient, he had gait issues/balance issues prior to the fall which resulted in him falling. He denies any red flag symptoms. Says that all of his symptioms started on 8/21 acutely prior to the fall. His symptoms caused him to fall, not the other way around and these symptoms were not related to a traumatic event. Denies clumsiness w/hands or generalized weakness. Denies prior hx or spine surgery.
The patient notes no urinary/stool incontinence, numbness/tingling. Also denies any HA, N/V, chest pain, abdominal pain, shortness of breath, and visual/hearing changes.
No known recent history of using aspirin, Plavix, warfarin, Lovenox, Pradaxa/Xarelto/Eliquis, or any other anticoaqgulants/antiplatelet meedications.
Procedure | LATERALITY | Date |
*ABDOMEN SURGERY | ||
*cataract surgery bilateral | ||
*ESOPHAGUS SURGERY esophageal carcinoma | ||
*HEMICOLECTOMY lap | Right | 9.29.14 |
* HIP SURGERY |
Recent Labs | |
---|---|
Lab | 08/21/23 1537 |
NA | 138 |
K | 4.7 |
CREAT | 1.17 |
GLU | 111 |
WBC | 7.1 |
HGB | 12.4* |
HCT | 37.5* |
PLT | 204 |
INR | 1.1 |
PRELIMINARY FINDINGS AND IMPRESSION:
BRAIN: No acute hemorrhage. No hemiation. Periventricular and deep white matter foci of T2/FLAIR signal hyperintensity, nonspecific, likely related to chronic microvascular ischemic change. No convincing evidence of any true reduced diffusion. Focal susceptibility signal in a region of FLAIR hyperintensity in the right centrum semiovale, most likely chronic microhemorrhage. Focal area of smooth dural thickening overlying the right frontal lobe measures up to 10 mm (series 600, image 441), is T1 isointense, mildly FLAIR hyperintense, and without abnormal susceptibility/reduced diffusion. There my be a thin posterior dural tail. Lesion is overall suggestive of a small meningioma without significant local mass effect. In retrospect this is visible on the recent companion CT brain but not on remote CT imaging from 2014. Ventricles within normal limits of size for age. No esxtra-axial collection. Maintained vascular flow voids.
CERVICAL SPINE: Multilevel cervical degenerative changes, including areas of disc osteophyte complex formation, uncovertebral hypertrophy, facet hypertrophy, and ligmentum flavum thickening, as suggested on CT. Ligamentum flavum thickening is mnore conspicuous on MRI, particularly at C5-C6. Findings are contributing to mild spinal canal narrowing at C3-C4, moderate to severe narrowing at C4-C5. severe narrowing at C5-C6, and moderate to severe narrowing at C7-T1. Mild deformity of the right lateral cord at C5-C6 due to external mass effect. No convincing evidence of any true cord signal abnormality. Degenerative neural foraminal narrowing, multilevel, is moderate to severe on the left at C2-C3, severe on the left at C3-C4 and C4-C5 (and moderate-to-severe on the right at C4-C5), and severe bilaterally at C5-C6. PRELIMINARY REPORT. FULL REPORT AND ADDITIONAL DETAILS TO FOLLOW.
XR Chest 1 View
Result Date: 8/21/2023
FINDINGS/IMPRESSION: Mild biapical scarring, lungs otherwise appear clear. No pleural effusion or pneumothorax. Unremarkable cardiac and mediastinal contours. Report dictated by: MV, MD, signed by: MVC, MD Department of Radioogy and Biomedical imaging.
1. No acute intracranial hemorrhage, hydrocephalus, or herniation.
2. No large vessel intracranial occlusion or significant arterial narrowing in the head or neck.
3. Multilevel cervical spondylosis, as described, with possibly severe narrowing of the bony spinal canal at C7-T1. The degree of bony canal stenosis is likely not significantly changed since 2015.
4. Findings possibly suggestive of right vocal cord paralysis; correlate with clinical symptoms.
//Noncontrast CT brain and CT angiography findings were discussed with Dr. G by BV, MD on 8/21/2023 at 1543 hours. Report dictated by BV, MD, signed by: XW, MD Department of Radiology and Biomedical Imaging.
PRELIMINARY FINDINGS AND IMPRESSION:
BRAIN: No acute hemorrhage. No herniation. Periventricular and deep white matter foci of T2/FLAIR signal hyperintensity, nonspecific, likely related to chronic microvascular ischemic change. No convincing evidence of any true reduced diffusion. Focal susceptibility signal in a region of FLAIR hyperintensity in the right centrum semiovale, most likely chronic microhemorrhage. Focal area of smooth dural thickening overlying the right frontal lobe measures up to 10 mm (series 600, image 441), is T1 isointense, mildly FLAIR hyperintense, and without abnormal susceptibility/reduced diffusion. There may be a thin posterior dural tail. Lesion is overall suggestive of a small meningioma without significant local mass effect. In retrospect this is visible on the recent companion CT brain but not on remote CT imaging from 2014. Ventricles within normal limits of size for age. No extra-axial collection. Maintained vascular flow voids.
CERVICAL SPINE: Multilevel cervical degenerative changes, including areas of disc osteophyte complex formation, uncovertebral hypertrophy, facet hypertrophy, and ligamentum flavum thickening, as suggested on CT. Ligamentum flavum thickening is more conspicuous on MRI, particularly at C5-C6. Findings are contributing to mild spinal canal narrowing at C3-C4, moderate to severe narrowing at C4-C5, severe narrowing at C5-C6, and moderate to severe narrowing at C7-T1. Mild deformity of the right lateral cord at C5-C6 due to external mass effect. No convincing evidence of any true cord signal abnormality. Degenerative neural foraminal narrowing, multilevel, is moderate to severe on the left at C2-C3, severe on the left at C3-C4 and C4-C5 (and moderate-to-severe on the right at C4-C5), and severe bilaterally at C5-C6. PRELIMINARY REPORT. FULL REPORT AND ADDITIONAL DETAILS TO FOLLOW
Assessment and Recommendations
[Patient tjr] 21155764 EDO2H/O2H
81M hx of fibromyalgia and multiple prior cancers (colon/esophageal/prostate) p/w acutely worsened gait since 8/21 w/falling to the L side (no trauma prior to gait difficulties) f/t/h cervical degenerative changea most severe at C5-C6 with central canal narrowing without cord signal change and R>L neuroforaminal stenosis from C2-C6. MRI Brain revealed an incidental 1.0 cm R frontal dural based mass without local mass effect or sulcal effacement concerning for a meningioma.
Exam: Aox3, EOMI, Face=, BUE/BLE 5/5, no hoffman's, no clonus, 2+ patellar reflexes. SILT, intention tremor present, exam w/component of rigidity.
ED Triage Notes
KHC at 8/21/2023 3:18 PMPhysical Exam
MSE differential diagnosis;
KG at 8/22/2023 11:30 AM
You were seen in the emergency department for weakness and problems walking. We examined you and did CT ansd MRI imaging of your brain and had our neurosurgeons and neurology doctors see you. We also had our physical therapy doctors see you and they recomnmended home health physical therapy which will have initiated the process of setting up for you. Please followq-up with your outpatient neurologisat to further assess your problems walking.
We also found that you have a urinary tract infection., We sent an antibiotic to your pharmacy that you wiil need to take for 7 days.
If you develop worse imbalance, falls, difficulty walking or any other concerning symptoms please retuirn to the emergency department.
CODE STROKE NOTE
CASE MANAGEMENT DISCHARGE
Final Discharge Note | |
*Primary Case Manager (First and Last Name) | HD |
Final Disdharge Disposition | Home Health Care (Non UCSF) |
Skilled or Acute needs | Physical Thrapy |
Patient Choice | CMS Provider List was given to patient and/or designee. Arrangementsa for the patient's first choice of provider have been made. Patient, family or legal decision maker, and team are in agreement with the discharge plan. |
Patient/Parent/Surrogaate Decision Maker agrres with the plan | Yes |
Home Care | |
Additional Instructions | Care In Touch Home Health ia obtaining authorization from your insurande will contact you | approved |
Transportation Arrangements | |
Date of Transport | 08/22/23 |
Final transportation arrangements | Self/Family/Caregiver (no assistance needed) |
CASE MANAGEMENT ASSESSMENT
Doctor's File Notes | History | Lab Test Results |
Medication | Symptoms | Table of Contents |